Stock Events

Stock Events

Currenc Group 

$1.44
0
-$0.03-2.04% Monday 07:08

Statistics

Day High
1.47
Day Low
1.37
52W High
-
52W Low
-
Volume
314
Avg. Volume
-
Mkt Cap
109.56M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

22AprExpected
Q3 2025
Next
-0.12
-0.06
-0.01
0.05
Expected EPS
-0.11
Actual EPS
N/A

Financials

-85.01%Profit Margin
Unprofitable
2021
2022
2023
2024
92.87MRevenue
-78.95MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CURR.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that develops and markets drugs in similar therapeutic areas as Avenir, making them direct competitors in the healthcare market.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotech firm focusing on novel therapies, including treatments for conditions that Avenir Wellness Solutions also targets.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a large pharmaceutical company with a diverse product portfolio that includes medications in direct competition with those of Avenir Wellness Solutions.
Merck
MRK
Mkt Cap214.76B
Merck operates globally in pharmaceuticals, including areas like immunotherapy and oncology, competing with Avenir's product lines.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie offers a range of biopharmaceuticals that directly compete with Avenir Wellness Solutions in multiple therapeutic areas.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb, with its broad range of pharmaceutical products, competes in the same market segments as Avenir Wellness Solutions.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company produces medicines in areas such as mental health and diabetes, overlapping with Avenir's market interests.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that produces drugs that directly compete with Avenir Wellness Solutions' offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson has a large portfolio of pharmaceuticals that includes competitive products in the wellness and therapeutic sectors targeted by Avenir.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals specializes in biopharmaceuticals, particularly in areas like immunology and oncology, which are key focus areas for Avenir Wellness Solutions.

About

Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. It provides its products in beauty, health and wellness, and pet care categories under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. The company sells its products through drug and grocery chains, convenience stores, and mass retailers. It also offers its products under private label to retailers and multi-level marketers, as well as DTC, via online website orders, including opt-in subscriptions. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in October 2022. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is headquartered in Sherman Oaks, California.
Show more...
CEO
Mr. Robert Davidson
Employees
11
Country
US
ISIN
KYG478621009

Listings

OTC Link
US
AVRW
XNAS
US
CURR
BOATS
BOATS
CURR.BOATS

0 Comments

Share your thoughts

FAQ

What is Currenc Group stock price today?▼
The current price of CURR.BOATS is $1.44 USD — it has decreased by -2.04% in the past 24 hours. Watch Currenc Group stock price performance more closely on the chart.
What is Currenc Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Currenc Group stocks are traded under the ticker CURR.BOATS.
What is Currenc Group market cap?▼
Today Currenc Group has the market capitalization of 109.56M
When is the next Currenc Group earnings date?▼
Currenc Group is going to release the next earnings report on April 22, 2026.
What were Currenc Group earnings last quarter?▼
CURR.BOATS earnings for the last quarter are 0.05 USD per share, whereas the estimation was -0.12 USD resulting in a +141.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Currenc Group revenue for the last year?▼
Currenc Group revenue for the last year amounts to 92.87M USD.
What is Currenc Group net income for the last year?▼
CURR.BOATS net income for the last year is -78.95M USD.
How many employees does Currenc Group have?▼
As of February 03, 2026, the company has 11 employees.
In which sector is Currenc Group located?▼
Currenc Group operates in the Health Care sector.
When did Currenc Group complete a stock split?▼
Currenc Group has not had any recent stock splits.
Where is Currenc Group headquartered?▼
Currenc Group is headquartered in Sherman Oaks, US.